At the beginning of 2020, we highlighted the story of Theranos, manufacturer of a “revolutionary” blood testing system that was supposedly able […]
Posts Tagged ‘FDA’
Professor and Entrepreneur
Twenty years ago, I published a commentary entitled “The professor as entrepreneur” in which I reflected on my decade as an academic […]
Breast Screening and Radiation
One of the reasons why some women are reluctant to subject themselves to an annual mammogram is a concern that […]
DBT vs FFDM – Again
In a recent paper published in JAMA Network Open, Kathryn Lowry (seen right) asked the question: Does screening performance of digital breast […]
The Next Unicorn
In the business world, a “unicorn” is the term used to indicate that a privately held startup company has a […]
DBT + AI = Progress
Despite a recent report calling into question the benefits of digital breast tomosynthesis (DBT) – sometimes called 3D mammography – as a […]
Does 3D Mammography Save More Lives?
A week ago, USA Today published an article written by Liz Szabo (seen right) with the provocative headline, “Massive marketing muscle pushes […]
HHUS versus ABUS
Fifteen years ago, Peter Dempsey wrote a fascinating article on the history of breast ultrasound that appeared in the Journal […]
The Evidence is Growing
The introduction of full-field digital mammography (FFDM) as a replacement for plane-film analogue mammography started over two decades ago. Shortly […]
Language of Breast Density
Over the years, we have written multiple articles about breast density, including its reduction, legislation, diagnostic challenges and workflow optimization. One may reasonably ask: Why this […]